Patterson Companies (PDCO) makes up 0.14% of the Health Care Select Sector SPDR ETF (XLV). PDCO has a market cap of ~$4.7 billion. The company operates in several countries and has a good flow of revenue. In this article, we will analyze the revenue trend of PDCO for the past few years.
Receive e-mail alerts for new research on PDCO:
Interested in PDCO?
Don’t miss the next report.
The above graph reflects the revenue trend of PDCO since 2010. The company’s revenue has been growing consistently every year. In 2014, the company’s revenue was $4.1 billion as compared to $3.63 billion in 2013. Revenue jumped by ~12% on a year-over-year basis. The growth was mainly attributable to the acquisition of National Veterinary Services (NVS), which immediately contributed to the revenue growth of the company. This acquisition also helped PDCO expand its footprint into the UK veterinary market.
PDCO’s revenue comes from three different streams. In 2014, Patterson Dental contributed 58%, Patterson Veterinary contributed 30%, and Patterson Medical contributed 12%.
The Patterson Veterinary division has outperformed other divisions in terms of growth, but it remains to be seen how things will shape up for the company in 2015.
For the period between August 25 and August 31, 2015, PDCO was down by 4.1% and some of its peers according to market cap like Dentsply International (XRAY), PerkinElmer (PKI), and Tenet Healthcare (THC) outperformed PDCO with returns of 1.67%, 5.94%, and 4.97%, respectively.